Research Topics
Species | R JakeszSummaryAffiliation: Medical University of Vienna Country: Austria Publications
| Collaborators
|
Detail Information
Publications
Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study GroupPeter C Dubsky
Medical University of Vienna, Austria
J Clin Oncol 30:722-8. 2012....
Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6aRaimund Jakesz
Department of Surgery, Vienna Medical University, Vienna General Hospital, Waehringer Guertel 18 20, Vienna A 1090, Austria
J Natl Cancer Inst 99:1845-53. 2007..We examined the efficacy and tolerability of extended adjuvant therapy with another aromatase inhibitor, anastrozole, for 3 years among women who had completed 5 years of adjuvant therapy...
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trialRaimund Jakesz
Austrian Breast and Colorectal Cancer Study Group ABCSG, Vienna Medical University, Vienna General Hospital, Waehringer Guertel 18 20, Vienna A 1090, Austria
Lancet 366:455-62. 2005..We investigate whether women who have received a period of adjuvant tamoxifen would benefit from being switched to anastrozole...
An update on ovarian suppression/ablationR Jakesz
Division of General Surgery, Vienna Medical School, Vienna, Austria
Int J Gynecol Cancer 16:511-4. 2006..Published reports have demonstrated that ovarian suppression is a safe means of reducing risk of recurrence in estrogen receptor-positive women and underlined its use as a competitive alternative to chemotherapy in this patient subset...
The adjuvant endocrine treatment revolution: focus on anastrozoleRaimund Jakesz
Vienna Medical School, Division of General Surgery, Waehringer Guertel 18 20, Vienna A 1090, Austria
Expert Opin Drug Metab Toxicol 2:301-12. 2006..The use of anastrozole is now widely accepted in advanced breast cancer and its superior efficacy and tolerability to tamoxifen has recently been demonstrated in early breast cancer...
Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancerR Jakesz
Department of Surgery, Internal Medicine, and Gynecology and Obstetrics, University of Vienna, Austria
J Clin Oncol 17:1701-9. 1999..To evaluate the outcome in patients with stage II hormone receptor-positive breast cancer treated or not treated with low-dose, short-term chemotherapy in addition to tamoxifen in terms of disease-free and overall survival...
Objectively measured breast symmetry has no influence on quality of life in breast cancer patientsR Exner
Department of Surgery, Medical University Vienna, Breast Health Care Center, Waehringer Guertel 18 20 Vienna, Austria
Eur J Surg Oncol 38:130-6. 2012..This study investigates how quality of life (QoL) of breast cancer patients is related to breast symmetry...
Intraoperative frozen section analysis for breast-conserving therapy in 1016 patients with breast cancerO Riedl
LKH Krems, Department of Surgery, Austria
Eur J Surg Oncol 35:264-70. 2009....
HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancerS F Schoppmann
Department of Surgery, Medical University of Vienna, Vienna, Austria
Ann Oncol 21:955-60. 2010..In addition to blocking of HER2/neu, tyrosine kinase significantly decreased VEGF-C expression in vitro...
Breast cancer chemoprevention - a vision not yet realizedP Blaha
Department of Surgery, Medical University of Vienna, Vienna General Hospital, Vienna, Austria
Eur J Cancer Care (Engl) 18:438-46. 2009..With promising results in adjuvant settings, aromatase inhibitors may deliver better prevention treatment options in the future, nevertheless, more research is needed to reliably predict risk on an individual basis in the future...
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudyMichael Gnant
Department of Surgery, Medical University of Vienna, General Hospital Vienna, Vienna, Austria
Lancet Oncol 9:840-9. 2008..The aim of this substudy is to gain insight into bone health in this setting...
Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian BreasRaimund Jakesz
Department of Surgery, Vienna University, Vienna General Hospital, Austria
J Clin Oncol 20:4621-7. 2002..The purpose of Austrian Breast and Colorectal Cancer Study Group Trial 5 was to compare the efficacy of a combination endocrine treatment with standard chemotherapy...
Video assistance reduces complication rate of thoracoscopic sympathicotomy for hyperhidrosisJ Zacherl
University Clinic of Surgery, Vienna General Hospital, Austria
Ann Thorac Surg 68:1177-81. 1999..However, up to 8% of patients experience Horner's syndrome, and about 50% show compensatory sweating. This study evaluates the role of video assistance in thoracoscopic sympathicotomy for primary hyperhidrosis of the upper limb...
Recent developments in breast-conserving surgery for breast cancer patientsF Fitzal
Department of Surgery, Medical University Vienna, Vienna, Austria
Langenbecks Arch Surg 394:591-609. 2009..This invited review deals with the latest knowledge regarding breast conserving therapy in breast conserving patients...
Efficacy and safety of thoracoscopic sympathicotomy for hyperhidrosis of the upper limb. Results of 734 sympathicotomiesC H Neumayer
, Allgemeines Krankenhaus der Stadt Wien, , Vienna, Austria
Ann Chir Gynaecol 90:195-9. 2001..7). CONCLUSIONS: We observed a significant decrease of the incidence of complete or incomplete Horner's syndrome and gustatory sweating when the procedure was guided by video-imaging while success rate was similar when compared with CTS...
Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort studyF Fitzal
Department of Surgery, Breast Health Center, Medical University Vienna, Waehringer Guertel 18 20, Vienna, Austria
Breast Cancer Res Treat 127:121-8. 2011..These patients, however, should not be treated with breast conservation in the absence of any proven response after nCT...
Prognostic relevance of three histological grading methods in breast cancerL Latinovic
Department of Clinical Pathology, University of Vienna, Vienna, Austria
Int J Oncol 19:1271-7. 2001..Also, we could demonstrate that histological grading in needle biopsies is reliable enough to allow a preoperative risk estimation...
Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancerSebastian F Schoppmann
Department of Surgery, University of Vienna, Vienna, Austria
Int J Cancer 104:677-82. 2003..Our results also suggest that due to the apparent interaction of Id-1 with the steroid-receptor system in breast cancer, hormonal therapies might influence Id-1 expression and its impact on clinical outcome...
Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapyGudrun Pohl
Department of Internal Medicine 1, Division of Oncology, University Hospital, Vienna, Austria
Breast Cancer Res Treat 78:97-103. 2003....
Improved quality of life after sympathetic block for upper limb hyperhidrosisP Panhofer
Department of General Surgery, University Clinic of Surgery, Medical University of Vienna, Austria
Br J Surg 93:582-6. 2006..011, Keller; P = 0.032, Milanez de Campos). CONCLUSION: Endoscopic sympathetic block at T4 leads to improved QoL. Both current questionnaires fulfilled validation criteria for disease-specific QoL instruments in upper limb hyperhidrosis...
Heat treatment of hepatocellular carcinoma cells: increased levels of heat shock proteins 70 and 90 correlate with cellular necrosisG Schueller
Department of Surgery, University Hospital Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria
Anticancer Res 21:295-300. 2001..We conclude that HSP expression in HepG2 cells can be enhanced by heat shock treatment in vitro. We suggest that this mechanism can be exploited in increasing tumor immunogenicity...
Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapyMargaretha Rudas
Department of Pathology, University of Vienna, Vienna, Austria
Breast Cancer Res Treat 81:149-57. 2003..Response to chemotherapy is not associated with pre- or postchemotherapy expression levels of these drug resistance proteins but time to progression may be influenced by prechemotherapy MRP1 expression...
Fulvestrant ('Faslodex') in pre-treated patients with advanced breast cancer: a single-centre experienceG G Steger
Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, 18 20 Währinger Gürtel, A 1090 Vienna, Austria
Eur J Cancer 41:2655-61. 2005..Fulvestrant was well tolerated; six patients experienced adverse events (all grade I/II). These data demonstrate that fulvestrant is an effective and well-tolerated therapy for patients with ABC progressing on prior therapies...
Selective resection of colorectal liver metastasesD Tamandl
Department of Surgery, Hepatobiliary Service, Vienna Medical University, Wahringer Gurtel 18 20, 1090 Vienna, Austria
Eur J Surg Oncol 33:174-82. 2007..Safety of liver surgery for colorectal cancer liver metastases after neoadjuvant chemotherapy has to be re-evaluated...
Her2 and progesterone receptor status are not predictive of response to fulvestrant treatmentRupert Bartsch
First Department of Medicine, Medical University of Vienna, Vienna, Austria
Clin Cancer Res 13:4435-9. 2007..In this study, we evaluated factors that are potentially predictive of response and time to progression in patients treated with fulvestrant...
Do we need HER-2/neu testing for all patients with primary breast carcinoma?Susanne Taucher
Department of Surgery, Vienna University Medical School, Vienna, Austria
Cancer 98:2547-53. 2003..The objective of the current study was to investigate the probability, calculated using parameters that are assessed routinely in clinical practice, that patients with breast carcinoma had positive HER-2/neu status...
Survival after surgical treatment of breast cancerSusanne Taucher
Department of Surgery, Vienna University Medical School, Waehringer Guertel 18 20, 1090 Vienna, Austria
Langenbecks Arch Surg 389:75-82. 2004..e. complete resection with tumour-free margins. Type and extent of breast surgery is dependent on tumour stage; beyond that and even more importantly, prognosis of an individual patient depends upon its stage at diagnosis...
Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancerSusanne Taucher
Department of Surgery, Vienna University Medical School, Vienna, Austria
Wien Klin Wochenschr 116:26-31. 2004..Since core needle biopsy is increasingly used for the diagnosis of breast cancer, the purpose of this study was to assess the reliability of HER2/neu evaluation using this technique in patients with primary breast cancer...
Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study GroupRaimund Jakesz
Department of Surgery, University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Ann Surg 237:556-64. 2003..To confirm evidence that breast-conserving treatment (BCT) does not impair the prognosis in breast cancer patients as compared to mastectomy and to argue that it be regarded as the treatment of choice in stage I and II disease...
Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancerMonika Schindl
Institute of Clinical Pathology, Department of Surgery, University of Vienna Medical School, , A-1090 Vienna, Austria
Clin Cancer Res 8:1831-7. 2002..Our results indicate that patients with advanced-stage breast cancers might profit from future therapies targeting HIF-1alpha...
Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapyS Taucher
Department of Surgery, Vienna University Medical School, Waehringer Guertel 18 20, Vienna A 1090, Austria
Endocr Relat Cancer 10:91-8. 2003..Preoperative cytotoxic chemotherapy induced a significant extent of variation in the steroid receptor expression of breast cancer cells...
Contralateral breast cancer: molecular differentiation between metastasis and second primary cancerE Janschek
Department of Surgery, University of Vienna, Austria
Breast Cancer Res Treat 67:1-8. 2001..We could also demonstrate that contralateral breast cancer spread does occur. Standard pathological assessment allowed a firm diagnosis only in the presence of different histological types...
Lymph node ratio after curative surgery for intrahepatic cholangiocarcinomaD Tamandl
Departments of Surgery, Medical University of Vienna, Vienna, Austria
Br J Surg 96:919-25. 2009..Intrahepatic cholangiocarcinoma (ICC) is rare but its incidence is rising worldwide. The value of lymph node dissection for ICC is under discussion; the current staging systems do not differentiate between numbers of involved nodes...
Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancerSusanne Taucher
Department of Surgery, Vienna University Medical School, Vienna, Austria
Breast Cancer Res Treat 82:207-13. 2003....
Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancerCatharina Wenzel
Department of Internal Medicine I, Division of Oncology, University of Vienna, Vienna, Austria
Anticancer Drugs 16:441-5. 2005..We conclude that outpatient TEX+P is safe in the neoadjuvant treatment of patients with primary breast cancer. Thus, this regimen can be considered for further clinical trials...
Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patientsFlorian Fitzal
Department of Surgery, General Hospital, University Vienna, Waehringer Guertd 18 20, 1090 Vienna, Austria
Breast Cancer Res Treat 97:9-15. 2006..The impact of this observation on local recurrence and overall survival rate is, however, not fully investigated...
New epidemiological aspects of patients with severe hyperhidrosis presenting for sympathetic surgeryD Karimian-Teherani
Division of General Dermatology, Medical University of Vienna, Vienna, Austria
J Eur Acad Dermatol Venereol 23:651-5. 2009..Epidemiological data on individuals suffering from severe primary hyperhidrosis are scarce...
An oncoplastic procedure for central and medio-cranial breast cancerF Fitzal
Department of Surgery, Medical University Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
Eur J Surg Oncol 33:1158-63. 2007..The technique may be used for breast cancer at various locations and reduces scar visibility and morbidity...
Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancerSebastian F Schoppmann
Department of Surgery, University of Vienna, Waehringer, Vienna, Austria
Breast Cancer Res Treat 99:135-41. 2006....
Predictors for complications after loop stoma closure in patients with rectal cancerHerwig Pokorny
Department of Surgery, University Hospital of Vienna, 21A Währinger Gürtel 18 20, 1090, Vienna, Austria
World J Surg 30:1488-93. 2006..This unmatched case control study was undertaken to evaluate factors contributing to surgery-related complications of loop stoma closure in patients with rectal cancer...
Mortality and complications after stoma closureHerwig Pokorny
Department of Surgery, University Hospital of Vienna, 21 A Wāhringer Gürtel 18 20, 1090 Vienna, Austria
Arch Surg 140:956-60, discussion 960. 2005..This study was undertaken to evaluate factors contributing to hospital mortality and complications of stoma closure...
Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?Michael Gnant
Department of Surgery, Medical University of Vienna, Vienna, Austria
Clin Breast Cancer 9:S18-27. 2009..Results from ongoing studies are expected to further elucidate the benefits of bisphosphonates in maintaining bone health and improving clinical outcomes in patients with breast cancer...
Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapyMartin Filipits
Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Borschkegasse 8a, A 1090 Vienna, Austria
Clin Cancer Res 15:5888-94. 2009..The purpose of the present study was to assess the clinical relevance of p27 expression in postmenopausal hormone receptor-positive breast cancer patients who were treated with adjuvant tamoxifen therapy...
Endocrine therapy plus zoledronic acid in premenopausal breast cancerMichael Gnant
Medical University of Vienna, Austria
N Engl J Med 360:679-91. 2009..Aromatase inhibitors are superior to tamoxifen in postmenopausal patients, and preclinical data suggest that zoledronic acid has antitumor properties...
Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14Günther G Steger
Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
J Clin Oncol 25:2012-8. 2007..This phase III trial evaluated whether doubling the number of cycles of neoadjuvant treatment increased the pCR rate...
Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patientsFlorian Fitzal
Department of Surgery, Medical University Vienna, Waehringer Guertel 18 20, 1080 Vienna, Austria
Breast Cancer Res Treat 103:45-52. 2007..In special cancer centers up to 90% of patients are treated with BCT. T3/T4 breast cancer is one of the few contraindications for BCT. However, retrospective data suggest that BCT may be eligible in selected cases of T3/T4 breast cancer...
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapyPeter Dubsky
Department of Surgery, Medical University Vienna, Vienna, Austria
Clin Cancer Res 14:2082-7. 2008....
Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancerRichard Potter
Department of Surgery, Medical University of Vienna, Vienna, Austria
Int J Radiat Oncol Biol Phys 68:334-40. 2007..In women with favorable early breast cancer treated by lumpectomy plus tamoxifen or anastrazole, it remains unclear whether whole breast radiotherapy is beneficial...
Age, microbiology and prognostic scores help to differentiate between secondary and tertiary peritonitisPeter Panhofer
Department of General Surgery, E21 A, University Clinic of Surgery, Medical University of Vienna, Vienna, Austria
Langenbecks Arch Surg 394:265-71. 2009..The aim was to find significant risk factors for mortality and tertiary peritonitis including the Mannheim Peritonitis Index (MPI), the Acute Physiology and Chronic Health Evaluation (APACHE) II score, and a sumscore of both...
Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study GroupMichael F X Gnant
Department of Surgery, General Hospital, Medical University of Vienna, Vienna, Austria
J Clin Oncol 25:820-8. 2007..This study examined whether zoledronic acid can prevent bone loss associated with adjuvant endocrine therapy in premenopausal patients...
Breast-conserving therapy for centrally located breast cancerFlorian Fitzal
Department of Surgery, Medical University of Vienna, Austria
Ann Surg 247:470-6. 2008..To analyze whether breast-conserving therapy (BCT) may be an oncologically safe approach and result in a good cosmesis in patients with centrally located breast cancer (CLBC)...
Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSFCatharina Wenzel
Department of Internal Medicine I, Division of Clinical Oncology, Medical University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
Breast Cancer Res Treat 104:109-14. 2007..We questioned the impact of histologic type invasive ductal carcinoma (IDC) versus invasive lobular carcinoma (ILC) on response to primary chemotherapy...
Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancerAlexandra Resch
Department of Radiotherapy and Radiobiology, Vienna University, Medical School, General Hospital of Vienna, , Vienna, Austria
Radiother Oncol 63:47-58. 2002..This high-dose and large-volume interstitial BT seems to be superior to classical BCT without BT...
VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survivalSebastian F Schoppmann
Department of Surgery, University of Vienna, Austria
Surgery 139:839-46. 2006..Aim of this study was to clear the role of VEGF-C/D expressing TAMs in invasive breast cancer...
[Treatment of achalasia]Enrico P Cosentini
Klinische Abteilung für Allgemeinchirurgie, Universitatsklinik fur Chirurgie, Wien, Osterreich
Wien Klin Wochenschr 116:296-304. 2004..This article aims to provide an overview of the development of the conservative and surgical treatment of achalasia...
How to pass on expertise: pancreatoduodenectomy at a teaching hospitalPeter Wamser
Surgical Department, Division of General Surgery, University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
World J Surg 26:1458-62. 2002..Under direct supervision of an experienced surgeon PD can be performed safely as a teaching operation. A caseload of at least one resection per year seems necessary for consistently good results...
Pattern of hormone receptor status of secondary contralateral breast cancers in patients receiving adjuvant tamoxifenThomas Bachleitner-Hofmann
Department of Surgery, University of Vienna, A-1090 Vienna, Austria
Clin Cancer Res 8:3427-32. 2002....
Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancerWolfgang J Kostler
Clinical Division of Oncology, Department of Medicine I, University Hospital of Vienna, Vienna, Austria
Anticancer Res 24:1127-30. 2004....
Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancerSebastian F Schoppmann
Department of Surgery, Medical University of Vienna, Austria
Ann Surg 240:306-12. 2004..The aim of this study was to investigate the prognostic relevance of lymphangiogenesis and lymphovascular invasion in a large cohort of breast cancer patients...
Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study GroupMartin Filipits
Department of Internal Medicine I, Clinical Division of Oncology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
J Clin Oncol 23:1161-8. 2005..Therefore, we determined the impact of MRP1 expression on the clinical outcome of adjuvant therapy in patients with early-stage breast cancer...
Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cellsPeter C Dubsky
Vienna Medical School, Department of Surgery, A 1090 Wien, Wahringer Gurtel 18 20, Austria
Clin Chim Acta 364:139-47. 2006..Recent evidence suggests MPA to affect antigen-presenting cells...
Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancerR Jakesz
The Department of Surgery, University of Vienna, Waehringer Guertel 18 20, A 1090, Vienna, Austria
Eur J Cancer 38:327-32. 2002..We argue that selection of adjuvant systemic therapy for premenopausal breast cancer patients be increasingly guided by knowledge of the steroid hormone receptor levels...
Impact of pretreatment thrombocytosis on survival in primary breast cancerSusanne Taucher
Department of Surgery, University of Vienna Medical School, Waehringer Guertel 18 20, Vienna A 1090, Austria
Thromb Haemost 89:1098-106. 2003..1355). In our retrospective study, elevated platelet counts at time of diagnosis were associated with poor prognosis in breast cancer. We hypothesize that platelets may contribute to the pathophysiology of hematogenous metastasis...
Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastasesDietmar Tamandl
Department of Surgery, Medical University of Vienna, Vienna, Austria
Surgery 143:648-57. 2008..We investigated the value of preoperative staging on detection of additional resectable hepatic lesions in metastatic colorectal cancer patients...
Dendritic cell vaccination in medullary thyroid carcinomaAnton Stift
Department of Surgery, University of Vienna, Medical School, Vienna, Austria
Clin Cancer Res 10:2944-53. 2004..Palliative treatment options show no significant benefit. A promising treatment approach for human cancer is based on the vaccination of autologous dendritic cells (DCs)...
Limited endoscopic thoracic sympathetic block for hyperhidrosis of the upper limb: reduction of compensatory sweating by clipping T4C Neumayer
Department of General Surgery, University Clinic of Surgery, Vienna General Hospital, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
Surg Endosc 18:152-6. 2004..We present our experience and clinical results using this method, with emphasis on patients' quality of life...
The use of a breast symmetry index for objective evaluation of breast cosmesisF Fitzal
Department of Surgery, Medical University Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
Breast 16:429-35. 2007..9; p<0.05) and the BSI was able to significantly differentiate between good and bad cosmesis (BSI values from 0%d to 30%d is good, BSI>30%d is bad cosmesis). Thus the BSI may be used for clinical studies...
Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II)J Widder
Department of Radiotherapy and Radiobiology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Br J Cancer 92:1209-14. 2005..Bowel function was satisfactory after more than 5 years. Local control in primarily resectable rectal cancer after 10 x 2.5 Gy is excellent, warranting further evaluation of this treatment...
Analysis of hepatic resection of metastasis originating from gastric adenocarcinomaJohannes Zacherl
Department of Allgemeinchirurgie, Universitätsklinik für Chirurgie and Universität Wien, Vienna, Austria
J Gastrointest Surg 6:682-9. 2002..On the other hand, curative resection of metachronous liver metastases may allow long-term survival in selected patients...
Monitoring of circulating angiogenic factors in dendritic cell-based cancer immunotherapyChristine Brostjan
Department of General Surgery, General Hospital, University of Vienna, Vienna, Austria
Cancer 98:2291-301. 2003....
HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancerGerhild Fabjani
Department of Obstetrics and Gynecology, General Hospital of Vienna, Molecular Oncology Group, Waehringer Guertel 18 20, 5Q, A 1090 Vienna, Austria
Oncol Rep 14:737-41. 2005..0056). Although, HMGA2 obviously contributes to invasion it is not a specific marker for the detection of circulating tumor cells in peripheral blood...
Dendritic cell-based vaccination in solid cancerA Stift
Department of Surgery, University of Vienna Medical School, Vienna, Austria
J Clin Oncol 21:135-42. 2003..In this study, cancer patients with advanced disease that lacks defined tumor antigens were vaccinated with tumor lysate-pulsed DCs...
Teaching laparoscopic cholecystectomy: do beginners adversely affect the outcome of the operation?M Imhof
University Clinic of Surgery, University of Vienna, Vienna General Hospital, Vienna, Austria
Eur J Surg 168:470-4. 2002..To evaluate the safety of elective laparoscopic cholecystectomy (LC) as a supervised teaching procedure...
A genetically engineered influenza A virus with ras-dependent oncolytic propertiesM Bergmann
Department of Surgery, University of Vienna Medical School, Wahringer Gurtel 18 20, 1090 Vienna, Austria
Cancer Res 61:8188-93. 2001....
TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancerDaniela Kandioler
Department of Surgery, University of Vienna, Vienna, Austria
Ann Surg 235:493-8. 2002..To evaluate and compare the predictive power of p53 gene analysis versus p53 immunohistochemical staining in terms of response to preoperative short-term radiotherapy using 25 Gy in operable rectal cancer...
In vivo induction of dendritic cell-mediated cytotoxicity against allogeneic pancreatic carcinoma cellsAnton Stift
Department of Surgery, University of Vienna Medical School, A 1090 Vienna, Austria
Int J Oncol 22:651-6. 2003..Even though this study was confined to a single patient, the data might open a door for novel immunotherapeutical strategies...
Preventive mastectomy in patients at breast cancer risk due to genetic alterations in the BRCA1 and BRCA2 geneSusanne Taucher
Department of Surgery, Medical School, Vienna University, Waehringer Guertel 18 20, 1090 Vienna, Austria
Langenbecks Arch Surg 388:3-8. 2003..Despite the reduction in the risk of developing breast cancer, prophylactic mastectomy often leads to significant physical and psychological sequelae...
Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity?Felix B Langer
Department of Surgery, Division of General Surgery, Medical University of Vienna, Vienna, Austria
Obes Surg 16:166-71. 2006..The efficacy of laparoscopic sleeve gastrectomy (LSG) for morbidly obese patients with a BMI of <50 kg/m2 and the incidence of gastric dilatation following LSG have not yet been investigated...
Retroviral targeting of proliferating endothelial cellsAlexander Gornikiewicz
Department of Surgery, Vienna General Hospital, Medical University of Vienna, Vienna, Austria
Acta Biochim Pol 52:731-5. 2005..However, while being selective for proliferating human endothelial cells, the recombinant retroviral particles displayed low transduction efficiencies and thus have to be further improved...
Surgical treatment of severe acute pancreatitis: timing of operation is crucial for survivalPeter Götzinger
Department of Surgery, University of Vienna, Vienna, Austria
Surg Infect (Larchmt) 4:205-11. 2003..In patients operated on for severe acute pancreatitis (SAP) the impact of the timing of operation on outcome is controversial...
Current value of intraoperative sonography during surgery for hepatic neoplasmsJohannes Zacherl
Department of Surgery, Division of General Surgery, AKH 21 A, University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
World J Surg 26:550-4. 2002....
Experience with limited endoscopic thoracic sympathetic block for hyperhidrosis and facial blushingChristoph Neumayer
Dept of General Surgery, University Clinic of Surgery, Vienna General Hospital AKH E 21 A, Wahringer Gurtel 18 20, Vienna, 1090, Austria
Clin Auton Res 13:I52-7. 2003..3% and in the ESB3 group 13.9% were partly satisfied. Limited sympathetic surgery offers comparably high success and satisfaction rates along with a low rate of side effects...
Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancerCatharina Wenzel
Department of Internal Medicine I/Division of Oncology, University Hospital of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
Cancer Chemother Pharmacol 50:155-9. 2002..We recommend epidoxorubicin 30 mg/m(2) and docetaxel 35 mg/m(2) for further trials because of the high incidence of neutropenic fever and lymphocytopenia of WHO grade IV at dose levels 5 and 6...
Combined analysis of two phase II trials in patients with primary and advanced breast cancer with epidoxorubicin and docetaxel+granulocyte colony stimulating factorCatharina Wenzel
Department of Internal Medicine I, Division of Oncology, University Hospital of Vienna, 1090 Vienna, Austria
Anticancer Drugs 13:67-74. 2002..Thus, this regimen can be considered for further clinical trials...
Young age as an independent adverse prognostic factor in premenopausal patients with breast cancerPeter C Dubsky
Department of General Surgery, University of Vienna, Austria
Clin Breast Cancer 3:65-72. 2002..Future studies should focus on unveiling the young age surrogate in order to improve treatment and prognosis...
Survival of women with breast cancer in Austria by age, stage and period of diagnosisChristian Vutuc
Division of Epidemiology, Institute for Cancer Research, Medical School, University of Vienna, Austria
Wien Klin Wochenschr 114:438-42. 2002..To investigate survival of breast cancer patients by 1) age, 2) tumor stage and 3) period of diagnosis, also to determine the contribution of improvements in treatment and opportunistic mammography screening in Austria...
Preoperative second-line chemotherapy induces objective responses in primary breast cancerCatharina Wenzel
Division of Oncology, Department of Internal Medicine I, University Hospital of Vienna, Austria
Wien Klin Wochenschr 117:48-52. 2005..Thus, preoperative second-line chemotherapy appears to be justified when breast conservation is an important treatment goal and may have potential in improved tailoring of neoadjuvant treatments...
Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6Marianne Schmid
Medical Department, Graz University, and Second Department of Surgery, Graz Hospital, Graz, Austria
J Clin Oncol 21:984-90. 2003..To determine whether the addition of aminoglutethimide to tamoxifen is able to improve the outcome in postmenopausal patients with hormone receptor-positive, early-stage breast cancer...
Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trialPrudence Francis
Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne 8006, Australia
J Natl Cancer Inst 100:121-33. 2008..The Breast International Group 02-98 randomized trial tested the effect of incorporating docetaxel into anthracycline-based adjuvant chemotherapy and compared sequential vs concurrent administration of doxorubicin and docetaxel...
Treatment of breast cancer in countries with limited resourcesRobert W Carlson
Department of Medicine, Stanford University, Stanford, California 94305, USA
Breast J 9:S67-74. 2003..Efforts to reduce the number of breast cancers diagnosed at an advanced stage thus have the potential to improve rates of survival while decreasing the use of limited resources...
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapyMargaretha Rudas
Department of Pathology, Medical University of Vienna, Austria
Clin Cancer Res 14:1767-74. 2008..The objective of our study was to determine the clinical relevance of cyclin D1 expression in hormone receptor-positive breast cancer patients who were treated with tamoxifen-based therapy...
[New strategies against breast carcinoma. To outwit the resistance tendency of tumor cells]Raimund Jakesz
MMW Fortschr Med 147:8. 2005
High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelinGudrun Pohl
Department of Medicine I, Clinical Division of Oncology, University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria
J Clin Oncol 21:3594-600. 2003....
Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysisWalter Jonat
University of Kiel, Germany
Lancet Oncol 7:991-6. 2006..We aimed to investigate whether switching treatment of postmenopausal women with such breast cancer to anastrozole after 2-3 years of tamoxifen would be more effective than continuing on tamoxifen for a total of 5 years...
Preoperative therapy with epidoxorubicin and docetaxel plus trastuzumab in patients with primary breast cancer: a pilot studyCatharina Wenzel
Department of Internal Medicine I, Division of Oncology, University Hospital of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
J Cancer Res Clin Oncol 130:400-4. 2004..Thus, this regimen can be considered for further clinical trials...
Current status of neoadjuvant therapy for adenocarcinoma of the distal esophagusJohannes Zacherl
, , Allgemeines Krankenhaus der Stadt Wien, , A-1090 Vienna, Austria
World J Surg 27:1067-74. 2003..Neoadjuvant treatment of adenocarcinoma of the esophagus, as a consequence, is currently not the standard treatment and should be performed only within controlled clinical trials...
Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cellsGerd Schueller
Department of Radiology, University Hospital of Vienna Medical School, A 1090 Vienna, Austria
Int J Oncol 22:1397-402. 2003..The improved cellular immune response can be related to enhanced expression of HSP 70 and 90 in HepG2 cells upon hyperthermia...
